37270646|t|Targeted metabolomic analysis in Parkinson's disease brain frontal cortex and putamen with relation to cognitive impairment.
37270646|a|We performed liquid chromatography tandem mass spectrometry analysis with the targeted metabolomic kit Biocrates MxP Quant 500, in human brain cortex (Brodmann area 9) and putamen, to reveal metabolic changes characteristic of Parkinson's disease (PD) and PD-related cognitive decline. This case-control study involved 101 subjects (33 PD without dementia, 32 PD with dementia (cortex only), 36 controls). We found changes associated with PD, cognitive status, levodopa levels, and disease progression. The affected pathways include neurotransmitters, bile acids, homocysteine metabolism, amino acids, TCA cycle, polyamines, beta-alanine metabolism, fatty acids, acylcarnitines, ceramides, phosphatidylcholines, and several microbiome-derived metabolites. Previously reported levodopa-related homocysteine accumulation in cortex still best explains the dementia status in PD, which can be modified by dietary supplementation. Further investigation is needed to reveal the exact mechanisms behind this pathological change.
37270646	33	52	Parkinson's disease	Disease	MESH:D010300
37270646	103	123	cognitive impairment	Disease	MESH:D003072
37270646	256	261	human	Species	9606
37270646	352	371	Parkinson's disease	Disease	MESH:D010300
37270646	373	375	PD	Disease	MESH:D010300
37270646	381	383	PD	Disease	MESH:D010300
37270646	392	409	cognitive decline	Disease	MESH:D003072
37270646	461	463	PD	Disease	MESH:D010300
37270646	472	480	dementia	Disease	MESH:D003704
37270646	485	487	PD	Disease	MESH:D010300
37270646	493	501	dementia	Disease	MESH:D003704
37270646	564	566	PD	Disease	MESH:D010300
37270646	586	594	levodopa	Chemical	MESH:D007980
37270646	677	687	bile acids	Chemical	MESH:D001647
37270646	689	701	homocysteine	Chemical	MESH:D006710
37270646	727	730	TCA	Chemical	MESH:D014238
37270646	738	748	polyamines	Chemical	MESH:D011073
37270646	750	762	beta-alanine	Chemical	MESH:D015091
37270646	775	786	fatty acids	Chemical	MESH:D005227
37270646	788	802	acylcarnitines	Chemical	MESH:C116917
37270646	804	813	ceramides	Chemical	MESH:D002518
37270646	815	835	phosphatidylcholines	Chemical	MESH:D010713
37270646	901	909	levodopa	Chemical	MESH:D007980
37270646	918	930	homocysteine	Chemical	MESH:D006710
37270646	978	986	dementia	Disease	MESH:D003704
37270646	997	999	PD	Disease	MESH:D010300
37270646	Association	MESH:D007980	MESH:D003704
37270646	Association	MESH:D006710	MESH:D003704
37270646	Association	MESH:D006710	MESH:D010300
37270646	Positive_Correlation	MESH:D006710	MESH:D007980

